About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Should Income Investors Buy This Blue Chip Dividend Stock?
Tickers BMY
Tags Recent Press Releases BMY Market News
From Motley Fool
Insiders Selling Zoom Video Communications, Bristol-Myers Squibb And This Footwear Manufacturer
Tickers BMY SKX ZM
Tags Pre/Market Outlook BMY Market News
From Benzinga
7 Best Dividend Stocks to Buy Now in May 2023
Tickers BAC BMY DE DRI
Tags SWKS DE Recent Press Releases
From Motley Fool
Want Passive Income at a Fair Price? Consider Buying This Dividend Growth Stock
Tickers BMY NVO
Tags Market News Recent Press Releases BMY
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ABBV ALDX BMY CERE
Tags HIMS TDOC Benzinga
From Benzinga
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
Tickers BMY IMTX
Tags BMY General Top Stories
From Benzinga
Bristol-Myers Squibb Earnings Perspective: Return On Capital Employed
Tickers BMY
Tags BMY Benzinga Market News
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ALGN BMY CTLT CVS
Tags BMY PFE VEEV
From Benzinga
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down
Tickers BMY
Tags Guidance Earnings Large Cap
From Benzinga
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
Tickers BMY GSK LLY TNXP
Tags Tonix Pharmaceuticals Holding Biotech LLY
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
Tickers AAL ABBV AMGN AMZN
Tags COF META News
From Benzinga
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
Tickers BMY LIAN
Tags News General Health Care
From Benzinga
Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market – Interim Results Could Be Released In Second Half Of 2023
Tickers ALLR BMY
Tags Biotech Benzinga ALLR
From Benzinga
Bristol-Myers Squibb Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers BMY
Tags BZI/CONF Market News Benzinga
From Benzinga
This Supercharged Dividend King Stock Might Soon Run Out of Steam
Tickers ABBV ABT BMY GILD
Tags RXDX Market News JNJ
From Motley Fool
Want Consistently Growing Passive Income? Buy Johnson & Johnson Stock
Tickers BMY JNJ LLY
Tags LLY JNJ Market News
From Motley Fool
Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday
Tickers AUPH BMY
Tags Benzinga Biotech Market News
From Benzinga
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
Tickers BMY EXEL TLRY
Tags TLRY EXEL BMY
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
Tickers BMY
Tags Markets Benzinga BZI/UOA
From Benzinga
Thinking Of Buying Healthpeak Properties? Here Are The Properties And Tenants You'd Be Adding To Your Portfolio
Tickers AMGN BMY JNJ PEAK
Tags REIT Benzinga JNJ
From Benzinga
Where Bristol-Myers Squibb Stands With Analysts
Tickers BMY
Tags Benzinga BMY Market News
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
Tickers BMY JNJ LEGN NVS
Tags Market News JNJ LEGN
From Motley Fool
Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
Tickers BMY EVAX
Tags Movers Health Care Market News
From Benzinga
This House of Representative Just Sold Up To $265K In Bristol-Myers Squibb Stock
Tickers BMY
Tags Market News BMY General
From Benzinga
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
Tickers ABBV BMY JNJ MRK
Tags MRK RXDX JNJ
From MarketWatch
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Tickers ALLR BIIB BMY CLOV
Tags NVS NVAX NKTR
From InvestorPlace
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
Tickers BGNE BMY ENLV MRK
Tags MRK Partner Content BMY
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags DD General BMY
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags Benzinga Biotech SNY
From Benzinga
2 Top Stocks to Buy in April and Hold Forever
Tickers BMY SYK
Tags SYK Market News Recent Press Releases
From Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.